Khiron Life Sciences Corp.
KHRNF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 59.6% | -16.3% | 974.6% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 49.8% | 87.4% | 25.4% | 33.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -250.4% | -285.1% | -380.8% | -2,050.9% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -258.9% | -299.8% | -379.6% | -2,221.3% |
| EPS Diluted | -0.2 | -0.2 | -0.36 | -0.41 |
| % Growth | 0% | 44.4% | 12.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |